Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
09/2005
09/14/2005EP1572867A2 Endothelial cell expression patterns
09/14/2005EP1572719A2 Partial peptide mimetics and methods
09/14/2005EP1572300A1 Combination for the treatment of adhd
09/14/2005EP1572291A2 The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine
09/14/2005EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
09/14/2005EP1572238A1 Agent with a retarded release of substances
09/14/2005EP1572237A1 Combinations of vanilloid antagonist and nsaid for the treatment of pain
09/14/2005EP1572216A1 Steroid compositions for intraocular use
09/14/2005EP1572206A2 Compositions of non-steroidal anti-inflammatory drugs decongestants and anti-histamines
09/14/2005EP1572204A1 Synergistic compositions with analgesic properties comprising n-acylated 4-hydroxyphenylamine derivatives
09/14/2005EP1572202A2 Use of serotonin receptor antagonists for the treatment of sleep apnea
09/14/2005EP1572188A1 Pregabalin derivatives for the treatment of fibromyalgia and other disorders
09/14/2005EP1572187A1 Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders
09/14/2005EP1572186A2 Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents
09/14/2005EP1572184A1 Gabapentin analogues for fibromyalgia and other related disorders
09/14/2005EP1572183A1 Alpha-2-delta ligand for the treatment of sexual dysfunction
09/14/2005EP1572181A2 Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor and the use of said composition for treating bladder dysfunction
09/14/2005EP1572179A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor
09/14/2005EP1572174A1 Prevention and treatment of alzheimer's disease
09/14/2005EP1572173A1 Alpha-2-delta ligand to treat lower urinary tract symptoms
09/14/2005EP1572172A1 Alpha2delta ligands for different pharmaceutical uses
09/14/2005EP1572168A2 Anti-infarction molecules
09/14/2005EP1572156A1 Process for preparing combination pharmaceutical formulations using supercritical fluids
09/14/2005EP1572151A1 Liquid dosage forms of proton pump inhibitors
09/14/2005EP1572133A2 Method for identifying modulators of human orexin-2 receptor
09/14/2005EP1572128A2 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/14/2005EP1572126A2 Compositions and methods for altering glucose production
09/14/2005EP1572124A2 Hcv e1e2 vaccine compositions
09/14/2005EP1572122A2 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides
09/14/2005EP1572102A2 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
09/14/2005EP1572095A2 S-l-2 -deoxynucleosides for the treatment of resistant hbv strains and combination therapies
09/14/2005EP1572093A2 Improved treatment of cancer with glutamine
09/14/2005EP1572086A2 Methods and composition based on discovery of metabolism of nitroclycerin
09/14/2005EP1572083A2 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
09/14/2005EP1572078A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/14/2005EP1572076A2 Helical peptidomimetics
09/14/2005EP1572075A2 Method for treating diseases associated with abnormal kinase activity
09/14/2005EP1572073A2 Alteration of rab38 function to modulate mammalian pigmentation
09/14/2005EP1572072A2 Methods of treating infection by drug resistant bacteria
09/14/2005EP1572071A2 Systems and methods for treating patients with processed lipoaspirate cells
09/14/2005EP1572068A2 Arylheteroalkalylamine derivatives and their use as inhibitors of nitric oxide synthase
09/14/2005EP1515698A4 Liposomes containing biologically active compounds
09/14/2005EP1438060A4 Prevention and treatment of restenosis by local administration of drug
09/14/2005EP1399157B1 Combination comprising a p-gp inhibitor and an anti-epileptic drug
09/14/2005EP1140009B1 Absorbent article composition and use thereof for sequestering skin irritants.
09/14/2005EP1082141B1 Cd40 binding antibodies and ctl peptides for treating tumors
09/14/2005EP1077725B1 Topical pharmaceutical compositions useful for treating cutaneous or circulatory pathologies on inflammatory, immune, proliferative or degenerative basis, comprising pollen extract and vegetable oil unsaponifiables
09/14/2005EP1073418A4 Aqueous composition comprising active ingredients for the de-pigmentation of the skin
09/14/2005EP0904283B1 Human netrin-1
09/14/2005CN1668763A 1L1RL-1 as a cardiovascular disease marker and therapeutic target
09/14/2005CN1668762A Sgk and Nedd used as diagnostic and therapeutic targets
09/14/2005CN1668761A Therapeutic use of selective PDE10 inhibitors
09/14/2005CN1668750A Her-2/neu DNA vaccine having anti-cancer activity
09/14/2005CN1668733A Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes
09/14/2005CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer
09/14/2005CN1668609A Substituted 4-aryl-4H-pyrrolo[2, 3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/14/2005CN1668606A Oxazole derivatives and their use as insulin sensitizers
09/14/2005CN1668575A Tgents and methods for the treatment of disorders associated with oxidative stress
09/14/2005CN1668359A Thermotherapy method for treatment and prevention of breast cancer and cancer in other organs
09/14/2005CN1668328A Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells
09/14/2005CN1668326A Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668325A Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668320A Tablet composition containing chinese orthodox medicine extract and process for producing the same
09/14/2005CN1668316A Anti-spasmodic comprising xenon
09/14/2005CN1668314A Methods of treating hepatitis
09/14/2005CN1668305A Microbicidal pyrimidine or triazine for preventing sexual HIV transmission
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/14/2005CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/14/2005CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
09/14/2005CN1668294A Use of nefopam for the treatment of nausea or emesis
09/14/2005CN1668286A Combination of an IBAT inhibitor and a metal salt for the treatment of diarrhea
09/14/2005CN1668281A Nanoparticulate fibrate formulations
09/14/2005CN1667416A Diagnostics and therapeutics for glaucoma
09/14/2005CN1666742A Combination therapy to treat hepatitis b virus
09/14/2005CN1218698C Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis
09/14/2005CN1218694C Method for treating endometriosis or infertility, or improving fertility
09/13/2005US6943246 3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof
09/13/2005US6943240 Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonist
09/13/2005US6943189 mixture of sulfur compounds and 3-hydroxy-3-methylglutaryl-coenzyme A inhibitors, used for prophylaxis of hyperlipemia in mammals
09/13/2005US6943187 Shampoos for treating alopecia
09/13/2005US6943171 For therapy of urological, vascular or pulmonary disorders
09/13/2005US6943156 3-(5,6,7,8-Tetrahydro-(1,8)naphthyridin-2-yl)-ethoxy)-11H-di-b enzo(1,4)oxazepin-10-yl)-acetic acid; inhibiting bone resorption; vascular restenosis; osteoporosis; angiogenesis inhibitors; diabetic retinopathy; anticarcinogenic agents
09/13/2005US6943155 Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity
09/13/2005US6943151 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds
09/13/2005US6943148 Methods for delivering therapeutics across blood-barrier and for altering receptor binding affinity
09/13/2005US6943146 Control cell proliferation, cell differentiation; culture product
09/13/2005US6943024 A medium comprising serum, antibiotics, growth factors like hepatocyte growth factor, and epinephrine, for culturing the patient's skin in vitro to generate cell proliferation, migration behaviors and melanin production; treating skin disorder
09/13/2005US6943013 DNA expression vector; host cell transformed, transfected or infected with the vector; transgenic cell, tissue or organism; HCDS1 protein
09/13/2005US6943000 Detection of modulator of enzyme activity; obtain cells, incubate with modulator, monitor adjustment in enzyme activity, adjustment in activity indicates modulator
09/13/2005US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides
09/13/2005US6942983 An isolated monoclonal antibody is used for binding and detecting a polypeptide having amino acid sequence with valine at residue 835, modulate kinase activity in cells, protein kinase C
09/13/2005US6942879 Cells seeded hollow fibers; ultrafiltration
09/13/2005US6942877 Method for producing antibiotic composites
09/13/2005US6942876 Mixture of n-methyl-d-aspartate and nonsteroid antiinflammatory drug
09/13/2005US6942853 Latent fusion protein
09/13/2005CA2370920C Feedstock for prepartum dairy cattle
09/13/2005CA2368650C Viral treatment
09/13/2005CA2323863C Methods and compositions for treating and preventing mucositis
09/13/2005CA2314893C Opioid agonist/antagonist combinations
09/13/2005CA2279276C Arylsulfonylamino hydroxamic acid derivatives
1 ... 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 ... 1151